SK
Highly rated in
5
conditions
Highly rated in
5
conditions
Check Dr. Sandra K. Kostyk's experience treating your condition:
About Dr. Sandra K. Kostyk

Sandra Kostyk is a Neurologist and a Physiatrist in Columbus, Ohio. Kostyk has been practicing medicine for over 37 years and is highly rated in 5 conditions, according to our data. Her top areas of expertise are Huntington Disease, Mcleod Neuroacanthocytosis Syndrome, Chorea, and Drug Induced Dyskinesia. She is licensed to treat patients in Ohio. Kostyk is currently accepting new patients.

Her clinical research consists of co-authoring 26 peer reviewed articles and participating in 4 clinical trials in the past 15 years.

Insurance

MediFind strives to display the most accurate insurance information for every doctor. If you do not see your insurance listed for Dr. Sandra K. Kostyk it is best to call her office and ask if your insurance is accepted.

Accepts Medicare

Dr. Sandra K. Kostyk accepts the following insurance:

  •  Ambetter
  •  Molina Healthcare
  •  CareSource

Call to see if your plan is accepted.
Locations
2050 Kenny Rd, Columbus, OH 43221
Other Locations
2050 Kenny Rd, Columbus, OH 43221
Background & Education
Graduate Institution
University Of Chicago, Pritzker School Of Medicine, 1985.0
Specialties
Neurology
Physiatry
Licenses
Psychiatry & Neurology in OH
Hospital Affiliations
OhioHealth Riverside Methodist Hospital
The James Cancer Hospital And Solove Research Institute
Ohio State University Wexner Medical Center
Knox Community Hospital
Languages Spoken
English
Gender
Female
Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Doctors who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


4 Clinical Trials

Indirect and Out-of-Pocket Costs of Huntington's Disease in the United States
Impact of Xenazine(Tetrabenazine)on Gait and Functional Activity in Individuals With Huntington's Disease
View 1 Less Clinical Trial -

27 Total Publications

Safety and Tolerability of SRX246, a Vasopressin 1a Antagonist, in Irritable Huntington's Disease Patients-A Randomized Phase 2 Clinical Trial.
Summary: Safety and Tolerability of SRX246, a Vasopressin 1a Antagonist, in Irritable Huntington's Disease Patients-A Randomized Phase 2 Clinical Trial.


Save this doctor for later
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find a second opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn more
Similar Doctors